Regulatory Affairs Task ForceThe ‘Task Force on Regulatory Affairs and Clinical Use of EV-based Therapeutics‘ would like to work with stakeholders from regulatory authorities, academia, clinical research and other research institutions to contribute to the development of applicable regulatory guidance. We hope to jointly accelerate achieving the ultimate goal of a safe and efficient evaluation of EVs in clinical studies and eventually developing proven EV-based therapeutics. In pursuit of this goal, the Task Force and other ISEV members can serve as a valuable expert resource for basic and clinical researchers and for representatives of regulatory bodies.
Authority Representatives |